ArticleInfluenza and other respiratory viruses2025

Effectiveness of the XBB.1.5 COVID-19 Vaccines Against SARS-CoV-2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024.

Liliana Antunes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.